Marcus A. Wörns

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Sarah Berhane, Hidenori Toyoda, Toshifumi Tada et al. · Clinical Gastroenterology and Hepatology · 2016 · 311 citations

Hepatology, Balad-2 Serologic Models, Medicine +8

Concurrent Autoimmune Diseases in Patients With Autoimmune Hepatitis

Andreas Teufel, Arndt Weinmann, George J. Kahaly et al. · Journal of Clinical Gastroenterology · 2010 · 212 citations

Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation

Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman et al. · Journal of Hepatology · 2018 · 169 citations

Liver Fibrosis, Immunology, Pathology +16

Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis

Marcus A. Wörns, Arndt Weinmann, Kerstin Pfingst et al. · Journal of Clinical Gastroenterology · 2009 · 146 citations

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study

Michael Bitzer, Marius Horger, Edoardo G. Giannini et al. · Journal of Hepatology · 2016 · 134 citations

Shelter Study, Oncology, Hepatology +8